Literature DB >> 31209781

Bifunctional Labeling of Rabbit Mesenchymal Stem Cells for MR Imaging and Fluorescence Microscopy.

Markus T Berninger1,2, Pablo Rodriguez-Gonzalez3, Franz Schilling4, Bernhard Haller5, Thorsten Lichtenstein6, Andreas B Imhoff7, Ernst J Rummeny8, Martina Anton9, Stephan Vogt7, Tobias D Henning6,10.   

Abstract

PURPOSE: Longitudinal imaging studies are important in the translational process of stem cell-based therapies. Small animal imaging models are widely available and practical but insufficiently depict important morphologic detail. In contrary, large animal models are logistically challenging and costly but offer greater imaging quality. In order to combine the advantages of both, we developed an intermediate-sized rabbit animal model for cartilage imaging studies. PROCEDURES: Rabbit mesenchymal stem cells (rMSC) were isolated as primary cultures from the bone marrow of New Zealand white rabbits. rMSC were subsequentially transduced lentivirally with eGFP and magnetically labeled with the iron oxide ferucarbotran. eGFP expression was evaluated by flow cytometry and iron uptake was analyzed by isotope dilution mass spectrometry and Prussian blue staining. Fluorescence microscopy of eGFP-transduced rMSC was performed. Viability and induction of apoptosis were assessed by XTT and caspase-3/-7 measurements. The chondrogenic potential of labeled cells was quantified by glycosaminoglycan contents in TGF-β3 induced pellet cultures. Labeled and unlabeled cells underwent magnetic resonance imaging (MRI) at 1.5 T before and after differentiation using T1-, T2-, and T2*-weighted pulse sequences. Relaxation rates were calculated. rMSCs were implanted in fibrin clots in osteochondral defects of cadaveric rabbit knees and imaged by 7 T MRI. T2* maps were calculated. Statistical analyses were performed using multiple regression models.
RESULTS: Efficiency of lentiviral transduction was greater than 90 %. Fluorescence signal was dose dependent. Cellular iron uptake was significant for all concentrations (p < 0.05) and dose dependent (3.3-56.5 pg Fe/cell). Labeled rMSC showed a strong, dose-dependent contrast on all MR pulse sequences and a significant decrease in T2 and T2* relaxation rates. Compared with non-transduced or unlabeled controls, there were no adverse effects on cell viability, rate of apoptosis, or chondrogenic differentiation. MRI of labeled rMSCs in osteochondral defects showed a significant signal of the transplant with additional high-resolution anatomical information.
CONCLUSIONS: This intermediate-sized rabbit model and its bifunctional labeling technique allow for improved depiction of anatomic detail for noninvasive in vivo rMSC tracking with MRI and for immunohistological correlation by fluorescence microscopy.

Entities:  

Keywords:  Bifunctional labeling; Chondrogenic differentiation; Ferucarbotran; Fluorescence microscopy; MR imaging; Mesenchymal stem cells; Osteochondral defects; Rabbit; eGFP

Mesh:

Substances:

Year:  2020        PMID: 31209781     DOI: 10.1007/s11307-019-01385-8

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  56 in total

1.  Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides.

Authors:  Jeff W M Bulte; Dara L Kraitchman; Alastair M Mackay; Mark F Pittenger
Journal:  Blood       Date:  2004-11-15       Impact factor: 22.113

2.  Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment.

Authors:  Heike E Daldrup-Link; Martina Rudelius; Guido Piontek; Stephan Metz; Rosalinde Bräuer; Gerlinde Debus; Claire Corot; Jürgen Schlegel; Thomas M Link; Christian Peschel; Ernst J Rummeny; Robert A J Oostendorp
Journal:  Radiology       Date:  2005-01       Impact factor: 11.105

3.  Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents.

Authors:  Volker Mailänder; Myriam Ricarda Lorenz; Verena Holzapfel; Anna Musyanovych; Karin Fuchs; Markus Wiesneth; Paul Walther; Katharina Landfester; Hubert Schrezenmeier
Journal:  Mol Imaging Biol       Date:  2008-02-23       Impact factor: 3.488

4.  Autologous chondrocyte implantation: a long-term follow-up.

Authors:  Lars Peterson; Haris S Vasiliadis; Mats Brittberg; Anders Lindahl
Journal:  Am J Sports Med       Date:  2010-02-24       Impact factor: 6.202

Review 5.  Iron oxide MR contrast agents for molecular and cellular imaging.

Authors:  Jeff W M Bulte; Dara L Kraitchman
Journal:  NMR Biomed       Date:  2004-11       Impact factor: 4.044

6.  Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133.

Authors:  Reinhard Meier; Tobias D Henning; Sophie Boddington; Sidhartha Tavri; Sandeep Arora; Guido Piontek; Martina Rudelius; Claire Corot; Heike E Daldrup-Link
Journal:  Radiology       Date:  2010-05       Impact factor: 11.105

7.  Activation of an iron uptake mechanism from transferrin in hepatocytes by small-molecular-weight iron complexes: implications for the pathogenesis of iron-overload disease.

Authors:  D R Richardson; A C Chua; E Baker
Journal:  J Lab Clin Med       Date:  1999-02

8.  Magnetic resonance imaging using heparin-coated superparamagnetic iron oxide nanoparticles for cell tracking in vivo.

Authors:  Yong Hwa Hwang; Dong Yun Lee
Journal:  Quant Imaging Med Surg       Date:  2012-06

9.  Targeting of hematopoietic progenitor cells with MR contrast agents.

Authors:  Heike E Daldrup-Link; Martina Rudelius; Robert A J Oostendorp; Marcus Settles; Guido Piontek; Stefan Metz; Hilkea Rosenbrock; Ulrich Keller; Ulrich Heinzmann; Ernst J Rummeny; Jürgen Schlegel; Thomas M Link
Journal:  Radiology       Date:  2003-07-24       Impact factor: 11.105

Review 10.  The use of mesenchymal stem cells for cartilage repair and regeneration: a systematic review.

Authors:  Andy Goldberg; Katrina Mitchell; Julian Soans; Louise Kim; Razi Zaidi
Journal:  J Orthop Surg Res       Date:  2017-03-09       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.